India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The team will also assist the state health departments in terms of public health measures, management guidelines and protocols to manage the increasing cases of Avian Influenza
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
The CRL did not identify any outstanding scientific issues with the product.
Results reinforce commitment to next-generation oral SERD development programme
Subscribe To Our Newsletter & Stay Updated
